Compare ANGI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGI | TMCI |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.0M | 401.8M |
| IPO Year | 2017 | 2021 |
| Metric | ANGI | TMCI |
|---|---|---|
| Price | $12.02 | $2.70 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $18.20 | $7.07 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.43 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $1,057,636,000.00 | $218,879,000.00 |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | $4.89 | $1.07 |
| P/E Ratio | $16.71 | ★ N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $10.25 | $2.56 |
| 52 Week High | $20.70 | $10.79 |
| Indicator | ANGI | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 21.78 |
| Support Level | $11.20 | $2.56 |
| Resistance Level | $11.61 | $3.15 |
| Average True Range (ATR) | 0.41 | 0.23 |
| MACD | 0.25 | 0.05 |
| Stochastic Oscillator | 96.98 | 12.83 |
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.